Supporting Our Caregivers In ADRD Learning (SOCIAL)
SOCIAL
2 other identifiers
interventional
82
1 country
1
Brief Summary
Building on limitations of prior research, the investigators developed the Mindful and Self-Compassionate Care Program (MASC) to help caregivers of persons with Alzheimer Disease and Related Dementias (ADRD) manage stress associated with the general caregiver experience including stress stemming from managing challenging patient behaviors. MASC teaches: (1) mindfulness skills; (2) compassion and self-compassion skills; and (3) behavioral management skills. MASC also provides psychoeducation and group-based training and skill practice to facilitate skill uptake and integration within the caregiver experience and tasks. The main aim is to: Demonstrate feasibility, acceptability, credibility, fidelity, preliminary efficacy and evidence for proposed mechanism of MASC through a pilot randomized controlled trial. Relevant stakeholders (caregivers of persons with ADRD) will participate in the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 18, 2024
CompletedFirst Posted
Study publicly available on registry
February 23, 2024
CompletedStudy Start
First participant enrolled
March 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 28, 2025
CompletedFebruary 13, 2026
April 1, 2025
1.2 years
February 18, 2024
February 10, 2026
Conditions
Outcome Measures
Primary Outcomes (13)
Feasibility of Recruitment
The proportion of eligible participants who are eligible and choose to enroll in the study and the percentage of racial and ethnically diverse participants enrolled.
Baseline
Feasibility of Randomization
The percentage randomized who complete the post-test.
Baseline, Post intervention (6-8 weeks post baseline)
Feasibility of Assessment Measures
The proportion of participants who complete the study with less than 25% of missing questionnaires.
Baseline, Post-intervention (6-8 weeks post baseline), 3-months post intervention
Feasibility of Quantitative Measures
The benchmark of no questionnaires missing fully in ≥25% of caregivers.
Baseline, Post-intervention (6-8 weeks post baseline), 3-months post intervention
Adherence to treatment
The proportion of caregivers who attend at least 4 out of the 6 sessions out of all randomized caregivers. Adherence to treatment will be estimated for both HEP and MASC.
Post-intervention
Patient's Global Impression of Change (PGIC)
PGIC is a 7-point scale depicting a participant's rating of overall improvement. Participants rate their change as "very much improved", "much improved", "minimally improved", "no change", "minimally worse", "much worse" or "very much worse"
Post-intervention (6-8 weeks post baseline)
Perceptions of Questionnaire Battery
The 'Perceptions of Questionnaire Battery' qualitative measure assesses how appropriately the participants fill the questionnaires, address their perception of stress, emotional distress and all other questionnaires.
Post-intervention (6-8 weeks post baseline)
Adherence to Home Practice
The proportion of participants who complete weekly home practice.
Weekly (up to 6 weeks
Perceptions of Email and Text Reminders
Participants' perception of emails and text messages reminders. The single question -, "Do participants think that the number of emails/texts received was: too little, just enough, too much?"
Post-intervention (6-8 weeks post baseline)
Credibility and Expectancy
The Credibility and Expectancy Questionnaire (CEQ) assesses participants' perceptions that the treatment will work after participating in the intervention.
Baseline
Modified Perception of Global Improvement
The Modified Perception of Global Improvement (MPGI) is a global index designed to measure a participant's interpretation of changes in perceptions of stress following intervention.
(6-8 weeks post baseline)
Satisfaction with the Intervention
The investigators will use the Client Satisfaction Questionnaire (CSQ-3) to assess participants' satisfaction with the intervention.
Post-intervention (6-8 weeks post baseline)
Therapist Fidelity
Ability of therapist to deliver the content of each session (through therapist completed adherence checklists) and therapist fidelity (through independent review of recorded sessions by Co-Investigator).
Baseline through Post-intervention (6-8 weeks post baseline)
Other Outcomes (12)
Symptoms of Depression
Baseline, Post-intervention (6-8 weeks post baseline), 3-months post intervention
Mindfulness
Baseline, Post-intervention (6-8 weeks post baseline), 3-months post intervention
Perceived Stress Scale
Baseline, Post-intervention (6-8 weeks post baseline), 3-months post intervention
- +9 more other outcomes
Study Arms (2)
Mindful and Self-Compassionate Care Program (MASC)
EXPERIMENTALThe intervention arm will be comprised of: Six Virtual Group Sessions. The sessions will teach mindfulness, self-compassion and behavioral management skills. At Home Practice. After each group session, participants will have the opportunity to integrate the practices learned into their everyday life.
Health Education Program (HEP)
ACTIVE COMPARATORThe control arm will be comprised of: Six Virtual Group Sessions. The sessions will discuss caregiver stress, sleep hygiene, nutrition, and ways to stay physically active as a caregiver. At Home Practice. After each group session, participants will have the opportunity to complete journal exercises that encourage them to integrate the health information that they learn into their daily lives.
Interventions
The intervention arm will be comprised of: Six Virtual Group Sessions. The sessions will teach mindfulness, self-compassion and behavioral management skills. At Home Practice. After each group session, participants will have the opportunity to integrate the practices learned into their everyday life.
The control arm will be comprised of: Six Virtual Group Sessions. The sessions will discuss caregiver stress, sleep hygiene, nutrition, and ways to stay physically active as a caregiver. At Home Practice. After each group session, participants will have the opportunity to complete journal exercises that encourage them to integrate the health information that they learn into their daily lives.
Eligibility Criteria
You may qualify if:
- years or older
- English fluency and literacy
- Meeting criteria for being a caregiver (e.g., family or friend of a care recipient who provides unpaid care)
- Must live with and care for an individual with ADRD
- Must have been in a caregiver role for more than 6 months
- Must provide an average 4 hours of supervision or direct assistance per day for the are recipient
- Perceived Stress Scale-4 (4-item) version ≥ 6
- Had managed 1 or more behavioral symptoms in past month
You may not qualify if:
- Recent (within the past 6 weeks) change in prescribed medications for depression or anxiety
- Use of mindfulness apps or any meditation (more than 60 min/week in past 3 months)
- Involvement in another clinical trial for caregivers, a score ≥ 4 on the Portable Mental Status Questionnaire (PMSQ)
- No stated concerns or distress related to care recipient's disruptive behaviors
- Involvement in another clinical trial for caregivers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Massachusetts General Hospitallead
- National Institute on Aging (NIA)collaborator
- University of California, San Franciscocollaborator
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114-2524, United States
Related Publications (16)
2021 Alzheimer's disease facts and figures. Alzheimers Dement. 2021 Mar;17(3):327-406. doi: 10.1002/alz.12328. Epub 2021 Mar 23.
PMID: 33756057BACKGROUNDJutkowitz E, Kane RL, Gaugler JE, MacLehose RF, Dowd B, Kuntz KM. Societal and Family Lifetime Cost of Dementia: Implications for Policy. J Am Geriatr Soc. 2017 Oct;65(10):2169-2175. doi: 10.1111/jgs.15043. Epub 2017 Aug 17.
PMID: 28815557BACKGROUNDRoche V. The hidden patient: addressing the caregiver. Am J Med Sci. 2009 Mar;337(3):199-204. doi: 10.1097/MAJ.0b013e31818b114d.
PMID: 19282676BACKGROUNDSorensen S, Conwell Y. Issues in dementia caregiving: effects on mental and physical health, intervention strategies, and research needs. Am J Geriatr Psychiatry. 2011 Jun;19(6):491-6. doi: 10.1097/JGP.0b013e31821c0e6e. No abstract available.
PMID: 21502853BACKGROUNDBrodaty H, Donkin M. Family caregivers of people with dementia. Dialogues Clin Neurosci. 2009;11(2):217-28. doi: 10.31887/DCNS.2009.11.2/hbrodaty.
PMID: 19585957BACKGROUNDLewinsohn PM, Seeley JR, Roberts RE, Allen NB. Center for Epidemiologic Studies Depression Scale (CES-D) as a screening instrument for depression among community-residing older adults. Psychol Aging. 1997 Jun;12(2):277-87. doi: 10.1037//0882-7974.12.2.277.
PMID: 9189988BACKGROUNDLi MJ, Black DS, Garland EL. The Applied Mindfulness Process Scale (AMPS): A process measure for evaluating mindfulness-based interventions. Pers Individ Dif. 2016 Apr 1;93:6-15. doi: 10.1016/j.paid.2015.10.027.
PMID: 26858469BACKGROUNDCohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available.
PMID: 6668417BACKGROUNDRaes F, Pommier E, Neff KD, Van Gucht D. Construction and factorial validation of a short form of the Self-Compassion Scale. Clin Psychol Psychother. 2011 May-Jun;18(3):250-5. doi: 10.1002/cpp.702. Epub 2010 Jun 8.
PMID: 21584907BACKGROUNDPommier E, Neff KD, Toth-Kiraly I. The Development and Validation of the Compassion Scale. Assessment. 2020 Jan;27(1):21-39. doi: 10.1177/1073191119874108. Epub 2019 Sep 13.
PMID: 31516024BACKGROUNDSteffen AM, McKibbin C, Zeiss AM, Gallagher-Thompson D, Bandura A. The revised scale for caregiving self-efficacy: reliability and validity studies. J Gerontol B Psychol Sci Soc Sci. 2002 Jan;57(1):P74-86. doi: 10.1093/geronb/57.1.p74.
PMID: 11773226BACKGROUNDRussell DW. UCLA Loneliness Scale (Version 3): reliability, validity, and factor structure. J Pers Assess. 1996 Feb;66(1):20-40. doi: 10.1207/s15327752jpa6601_2.
PMID: 8576833BACKGROUNDDevilly GJ, Borkovec TD. Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry. 2000 Jun;31(2):73-86. doi: 10.1016/s0005-7916(00)00012-4.
PMID: 11132119BACKGROUNDMerz EL, Roesch SC, Malcarne VL, Penedo FJ, Llabre MM, Weitzman OB, Navas-Nacher EL, Perreira KM, Gonzalez F, Ponguta LA, Johnson TP, Gallo LC. Validation of interpersonal support evaluation list-12 (ISEL-12) scores among English- and Spanish-speaking Hispanics/Latinos from the HCHS/SOL Sociocultural Ancillary Study. Psychol Assess. 2014 Jun;26(2):384-94. doi: 10.1037/a0035248. Epub 2013 Dec 9.
PMID: 24320763BACKGROUNDAttkisson CC, Greenfield TK. The Client Satisfaction Questionnaire (CSQ) and Scales and the Service Satisfaction Scale-30 (SSS-30).
BACKGROUNDTravis A, O'Donnell A, Giraldo-Santiago N, Stone SM, Torres D, Adler SR, Vranceanu AM, Ritchie CS. Intervention for the Management of Neuropsychiatric Symptoms to Reduce Caregiver Stress: Protocol for the Mindful and Self-Compassion Care Intervention for Caregivers of Persons Living With Dementia. JMIR Res Protoc. 2024 Oct 11;13:e58356. doi: 10.2196/58356.
PMID: 39392675DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ana-Maria Vranceanu, PhD
Massachusetts General Hospital
- PRINCIPAL INVESTIGATOR
Christine Ritchie, MD, MSPH
Massachusetts General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
February 18, 2024
First Posted
February 23, 2024
Study Start
March 22, 2024
Primary Completion
May 28, 2025
Study Completion
May 28, 2025
Last Updated
February 13, 2026
Record last verified: 2025-04